🫀 Cardiovascular Update: Stroke Therapy Gains Ground, CRISPR Trials Advance, AI Detects Heart Disease and More
From early stroke recovery treatments to next-gen AI in echocardiography, this month’s cardiovascular updates are packed with clinical innovation, regulatory approvals, and AI-driven progress. Whether you’re a clinician, researcher, or life sciences strategist, these insights will keep you on the pulse of the industry.
📌 In This Episode:
💉 Early anticoagulant therapy may reshape post-stroke AF care
🧬 CRISPR Therapeutics advances with promising cardiac gene trials
🧠 Mayo Clinic’s AI tool detects cardiac amyloidosis with 93 percent specificity
🫀 FDA greenlights CorFlow’s MOCA-II trial for microvascular obstruction
🧬 Solid Biosciences begins gene therapy trial for CPVT
💊 Bayer’s finerenone approved for heart failure with preserved EF
🩺 Baxdrostat succeeds in resistant hypertension Phase III trials
⚡ FDA approves VARIPULSE system update for safer AF ablation
🤖 Australian AI model outperforms Agatston score in heart attack prediction
🔍 FDA clears real-time AI software for TAVI valve implantation guidance
👩⚕️ Women face higher graft failure post-CABG—clinical strategies must adapt
📊 European Heart Journal validates Mayo/Ultromics AI for amyloidosis
🏥 UChicago validates AI tool for amyloidosis detection with high specificity
📢 Stay Ahead in Cardiovascular Research!
✅ Like, share, and subscribe for weekly updates on heart failure, AFib, stroke, and more
#Cardiovascular #HeartHealth #StrokeCare #AIinMedicine #GeneTherapy #HeartFailure #Hypertension #HealthcareInnovation #LucidQuest #LQVentures #ClinicalTrials #MedicalAI